Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
DOI 10.1016/S0140-6736(22)02033-5 Over 48 weeks, average body weight fell by 24.2% in the highest-dose group, versus 2.1% on placebo (the inactive look-alike)
Clinical studies show that semaglutide GLP-1 can help people lose an average of 15% of their initial body weight over around 68 weeks
Clinical Benefits Beyond Blood Sugar Control The potential anti-inflammatory properties of GLP-1 receptor agonists may contribute to their demonstrated cardiovascular and renal benefits , which have been observed in large-scale cardiovascular outcome trials
Exenatide and liraglutide demonstrated the decrease of all-cause mortality, blood pressure values, weight reduction and improvement of dyslipidemia
US$ 21.20
US$ 21.56
US$ 25.99
US$ 20.43
US$ 28.80
US$ 21.12
US$ 23.99
US$ 20.90
US$ 27.38
US$ 23.33
US$ 21.62
US$ 22.31
US$ 20.61
